Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01422837 · ClinicalTrials.gov registry record

ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry

A clinical trial of Opioid Dependence, sponsored by Alkermes.

Completed
Registry status
403
Enrollment target
20
Study locations

NCT01422837 is a study of Opioid Dependence that has completed, run by Alkermes. The registered enrollment target is 403 participants, above the 144-participant average among 29 other Opioid Dependence trials with a reported enrollment target (180% higher). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01422837, a study of Opioid Dependence, has completed, sponsored by Alkermes.

COMPLETED
Registry status
403 participants
Enrollment target
20
Study locations

Study Summary

The objective of the VIVITROL Registry is to gather real world data on opioid dependence and to provide understanding of the health economics of opioid dependence.

Conditions Studied

Study Locations (20)

California

  • Amy Solomon, MD - Ben Lomond
  • Touchstone Medical Group - Clovis
  • Kenneth C. Russ, MD - Palm Springs
  • Tarzana Treatment Centers - Tarzana

New York

  • Dent Neurologic Institute - Amherst
  • Dr. Michael Sanders - Great Neck
  • Fakhouri Medical - Hopewell Junction
  • Parallax Center - New York

Florida

  • Jacqueline Boutrouille, MD - Tamarac
  • Alliance Clinical Research - Winter Park

Georgia

  • Atlanta Institute of Medicine and Research - Atlanta
  • PACT Atlanta - Decatur

Massachusetts

  • Gosnold-Thorne Counseling Center - Centerville
  • Dr. Li's Clinic - Milford

Arizona

  • Assisted Recovery Centers of America - Phoenix

Arkansas

  • Arkansas Psychiatric Clinc - Little Rock

Colorado

  • The NeuroBehavioral Institute of Colorado, PC - Lone Tree

Trial Details

FieldValue
Enrollment Target 403 participants
Start Date 2011-08
Est. Completion 2013-10

Sponsor

Alkermes

66 total trials

What the Registry Record Tells You About NCT01422837

The ClinicalTrials.gov registry entry for NCT01422837 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 403 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 144-participant average among 29 other Opioid Dependence trials with a reported enrollment target (180% higher). The listed sponsor is Alkermes, which has 66 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Dependence appearing as the primary indexed condition, and to 0 interventions.

NCT01422837 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, New York, Florida.

Frequently Asked Questions

What is clinical trial NCT01422837 about?

NCT01422837 is a clinical study titled "ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry". The objective of the VIVITROL Registry is to gather real world data on opioid dependence and to provide understanding of the health economics of opioid dependence.

What is the current status of trial NCT01422837?

This trial is currently completed. The enrollment target is 403 participants. The study started on 2011-08. Estimated completion is 2013-10.

What conditions does trial NCT01422837 study?

This clinical trial studies the following conditions: Opioid Dependence.

Who is sponsoring clinical trial NCT01422837?

This trial is sponsored by Alkermes, which has 66 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01422837 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.